K. Neukam, S. Bhagani, A. Rodger, J. Oben, Divyabala Nirmal, Anjly Jain, D. Nair
{"title":"伦敦北部古吉拉特印度人中非酒精性脂肪性肝病(NAFLD)的高患病率:一项基于人群的研究","authors":"K. Neukam, S. Bhagani, A. Rodger, J. Oben, Divyabala Nirmal, Anjly Jain, D. Nair","doi":"10.1080/17584299.2017.1326709","DOIUrl":null,"url":null,"abstract":"ABSTRACT Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) among Indian Asians in high-income countries is not well studied, but appears to be different from that for Western populations. Design: Cross-sectional study of subjects recruited through a community cardiovascular (CV) screening programme at two London Hindu temples from 2010–2012. NAFLD was diagnosed using the fatty liver index (FLI) and fibrosis stage through the BARD (Body Mass Index (BMI), Aspartate aminotransferase to Alanine aminotransferase ratio and Diabetes Mellitus) score. Results: 597 subjects were assessed; 306 (51%) female. Median (interquartile range) age and BMI were 49 (40.6–55.0) years and 26.4 (23.5–29.2) kg/m2, respectively. NAFLD was diagnosed in 184 (30.8%) cases, but 175 (29.3%) subjects could not be categorised. Overall, 117 (40.2%) men and 67 (21.9%) women had evidence of NAFLD (p < 0.001). In those with evidence of NAFLD, 142 (78.5%) had a BARD score suggestive of advanced fibrosis. Advanced fibrosis could be excluded in 5 (7.6%) women and 34 (29.6%) men (p < 0.001). Total cholesterol (TC), triglycerides (TG) and non-HDL (high-density lipoprotein cholesterol) were higher in the NAFLD group (p < 0.001), whereas HDL-C was lower (p < 0.001). Conclusion: There is evidence of a high prevalence of asymptomatic NAFLD, possibly in combination with advanced liver damage, among UK-based Gujarati Indians living in London. NAFLD is emerging as an independent risk factor for CV disease. Screening programmes should be developed in order to decrease liver and CV mortality and morbidity in these high-risk patients.","PeriodicalId":55252,"journal":{"name":"Clinical Lipidology","volume":"25 1","pages":"33 - 39"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":"{\"title\":\"High prevalence of non-alcoholic fatty liver disease (NAFLD) among Gujarati Indians in North London: a population-based study\",\"authors\":\"K. Neukam, S. Bhagani, A. Rodger, J. Oben, Divyabala Nirmal, Anjly Jain, D. Nair\",\"doi\":\"10.1080/17584299.2017.1326709\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) among Indian Asians in high-income countries is not well studied, but appears to be different from that for Western populations. Design: Cross-sectional study of subjects recruited through a community cardiovascular (CV) screening programme at two London Hindu temples from 2010–2012. NAFLD was diagnosed using the fatty liver index (FLI) and fibrosis stage through the BARD (Body Mass Index (BMI), Aspartate aminotransferase to Alanine aminotransferase ratio and Diabetes Mellitus) score. Results: 597 subjects were assessed; 306 (51%) female. Median (interquartile range) age and BMI were 49 (40.6–55.0) years and 26.4 (23.5–29.2) kg/m2, respectively. NAFLD was diagnosed in 184 (30.8%) cases, but 175 (29.3%) subjects could not be categorised. Overall, 117 (40.2%) men and 67 (21.9%) women had evidence of NAFLD (p < 0.001). In those with evidence of NAFLD, 142 (78.5%) had a BARD score suggestive of advanced fibrosis. Advanced fibrosis could be excluded in 5 (7.6%) women and 34 (29.6%) men (p < 0.001). Total cholesterol (TC), triglycerides (TG) and non-HDL (high-density lipoprotein cholesterol) were higher in the NAFLD group (p < 0.001), whereas HDL-C was lower (p < 0.001). Conclusion: There is evidence of a high prevalence of asymptomatic NAFLD, possibly in combination with advanced liver damage, among UK-based Gujarati Indians living in London. NAFLD is emerging as an independent risk factor for CV disease. Screening programmes should be developed in order to decrease liver and CV mortality and morbidity in these high-risk patients.\",\"PeriodicalId\":55252,\"journal\":{\"name\":\"Clinical Lipidology\",\"volume\":\"25 1\",\"pages\":\"33 - 39\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"11\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lipidology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/17584299.2017.1326709\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lipidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17584299.2017.1326709","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}
High prevalence of non-alcoholic fatty liver disease (NAFLD) among Gujarati Indians in North London: a population-based study
ABSTRACT Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) among Indian Asians in high-income countries is not well studied, but appears to be different from that for Western populations. Design: Cross-sectional study of subjects recruited through a community cardiovascular (CV) screening programme at two London Hindu temples from 2010–2012. NAFLD was diagnosed using the fatty liver index (FLI) and fibrosis stage through the BARD (Body Mass Index (BMI), Aspartate aminotransferase to Alanine aminotransferase ratio and Diabetes Mellitus) score. Results: 597 subjects were assessed; 306 (51%) female. Median (interquartile range) age and BMI were 49 (40.6–55.0) years and 26.4 (23.5–29.2) kg/m2, respectively. NAFLD was diagnosed in 184 (30.8%) cases, but 175 (29.3%) subjects could not be categorised. Overall, 117 (40.2%) men and 67 (21.9%) women had evidence of NAFLD (p < 0.001). In those with evidence of NAFLD, 142 (78.5%) had a BARD score suggestive of advanced fibrosis. Advanced fibrosis could be excluded in 5 (7.6%) women and 34 (29.6%) men (p < 0.001). Total cholesterol (TC), triglycerides (TG) and non-HDL (high-density lipoprotein cholesterol) were higher in the NAFLD group (p < 0.001), whereas HDL-C was lower (p < 0.001). Conclusion: There is evidence of a high prevalence of asymptomatic NAFLD, possibly in combination with advanced liver damage, among UK-based Gujarati Indians living in London. NAFLD is emerging as an independent risk factor for CV disease. Screening programmes should be developed in order to decrease liver and CV mortality and morbidity in these high-risk patients.
期刊介绍:
The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal''s readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.